Relaksedin

General characteristics. Structure:

Active ingredients: 0,582 mg of a valerian of aqueous-alcoholic extract dry standardized (0,5 – 0,8% or 0,8% of valerenovy acids) in terms of the sum of valerenovy and atsetoksivalerenovy acids, 2 mg of a melissa of leaves of aqueous-alcoholic extract dry standardized (4-7% of rosemary acid) in terms of rosemary acid.

The vegetable drug possessing sedative action, facilitating approach of a dream and improving quality of a dream.

Pharmacological properties:

Pharmacodynamics. Medicine Relaksedin contains a combination of dry extracts of a root of a valerian and leaves of a melissa.

Experience of traditional use showed that extracts of a root of a valerian and leaves of a melissa possess sedative action, facilitate approach of a dream and improve quality of a dream.

The specified effects cannot be explained with action of any one component of extracts of a root of a valerian or leaves of a melissa. Some mechanisms of action which cause these clinical effects, were defined for various components of a root of a valerian (sesquiterpenoids, lignana, flavonoids) and adenosine receptors and 5-HT1A receptors include influence on GAMK-system, A1. Sedation when using drugs of a valerian is shown slowly, but rather steadily and completely develops only at systematic course treatment.

Pharmacokinetics. Pharmacokinetic parameters are not studied as medicines of a plant origin contain various biologically active agents.

Indications to use:

Medicine Relaksedin is applied in complex therapy of not heavy functional disturbances of the central nervous system (a neurasthenia and sleep disorders).

Route of administration and doses:

To adults and children 12 years are more senior. At the increased nervous irritability, irritability accept 2 capsules 2 times a day.

At sleep disorders reception of 1 capsule for half an hour – before going to bed is recommended 1 hour.

Capsules should be accepted, washing down with a small amount of boiled water of room temperature (1/4 glasses), irrespective of meal.

The effect of medicine reception Relaksedin develops gradually. For achievement of optimum effect reception of medicine within not less than 14 days is recommended. After the termination of treatment there is no development of symptoms of dependence or a withdrawal.

Duration of reception is defined individually with features of the disease reached effect and portability of medicine.

Features of use:

Due to the lack of sufficient data it is not recommended to apply at children up to 12 years.

Because of gradual development of effect it is not recommended to apply medicine in cases of the emergency need of reduction of symptoms of a hyperphrenia and sleep disorders. If symptoms remain against the background of reception of medicine or there is an aggravation of symptoms, it is necessary to see a doctor.

During treatment it is necessary to refuse driving of motor transport and work with moving mechanisms.

Side effects:

Frequency of the side reactions which are listed below: very often (> 1/100), it is frequent (> 1/100, <1/10), infrequently (> 1/1000, <1/100), is rare (> 1/10 000, <1/1000), is very rare (<1/10 000), it is not known (it cannot be estimated on the basis of available data).

Development of allergic reactions is possible

Gastrointestinal frustration. It is not known: nausea, abdominal cavity pains of spastic character. Strengthening of symptoms of a gastroesophageal reflux (heartburn) is possible. In case of the side reactions including which are not specified in the application instruction it is necessary to see a doctor.

Interaction with other medicines:

The concomitant use of medicine Relaksedin with synthetic sedatives (for example, benzodiazepines) is not recommended and allowed only under observation of the doctor.

Contraindications:

- hypersensitivity to the components which are a part of drug;
- pregnancy and period of a lactation;
- children's age up to 12 years;
- arterial hypotension.

Storage conditions:

Drug should be stored in the unavailable to children, protected from moisture and light place at a temperature from 15 °C to 25 °C. A period of validity - 2 years.

Issue conditions:

Without recipe

Packaging:

On 10 capsules in blister strip packagings, on 3 or 4 strip packagings in cardboard boxes.